IOL Chemicals & Pharmaceuticals Complete Financial Statements
IOLCP • Review detailed financials to uncover trends, confirm thesis & journal trades
4 Years of Data
2025 - 2022
Complete Financial Data Export
Export complete financial statements for IOL Chemicals & Pharmaceuticals (IOLCP).
Downloads include all available records across all periods.
Profitability Ratios
Net Profit Margin
5.23%
2025 data
EBITDA Margin
11.15%
2025 data
Operating Margin
10.00%
2025 data
Return on Assets
1.26%
2025 data
Return on Equity
1.78%
2025 data
Balance Sheet Ratios
Current Ratio
13.54
2025 data
Equity Ratio
70.86%
2025 data
Asset Turnover
0.24
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+7.9%
Year-over-Year
Net Profit Growth
+57.9%
Year-over-Year
EBITDA Growth
+33.3%
Year-over-Year
Expense Growth
+5.6%
Year-over-Year
Assets Growth
+6.1%
Year-over-Year
Equity Growth
+4.7%
Year-over-Year
Operating Cash Flow Growth
-38.3%
Year-over-Year
Investing Cash Flow Growth
+19.4%
Year-over-Year
Financing Cash Flow Growth
+149.5%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 574 | 532 | 559 | 586 | 532 | 511 | 510 | 527 | 552 | 596 | 570 | 529 | 547 | 579 | 570 | 530 |
| Expenses | 511 | 465 | 490 | 534 | 484 | 454 | 451 | 476 | 481 | 492 | 491 | 476 | 510 | 527 | 509 | 481 |
| EBITDA | 64 | 67 | 70 | 51 | 48 | 57 | 59 | 51 | 71 | 104 | 80 | 53 | 37 | 52 | 61 | 49 |
| Operating Profit Margin % | 10.00% | 12.00% | 11.00% | 8.00% | 8.00% | 10.00% | 10.00% | 9.00% | 12.00% | 16.00% | 13.00% | 9.00% | 6.00% | 8.00% | 10.00% | 8.00% |
| Depreciation | 20 | 19 | 20 | 20 | 18 | 16 | 17 | 19 | 16 | 12 | 14 | 16 | 11 | 11 | 11 | 12 |
| Interest | 4 | 4 | 4 | 4 | 4 | 3 | 2 | 5 | 4 | 5 | 4 | 4 | 4 | 2 | 3 | 5 |
| Profit Before Tax | 41 | 45 | 46 | 28 | 26 | 37 | 40 | 28 | 51 | 87 | 61 | 32 | 22 | 39 | 47 | 33 |
| Tax | 11 | 13 | 12 | 7 | 7 | 10 | 10 | 7 | 13 | 22 | 15 | 9 | 6 | 9 | 12 | 9 |
| Net Profit | 30 | 31 | 34 | 21 | 19 | 28 | 30 | 21 | 38 | 65 | 46 | 23 | 16 | 30 | 35 | 24 |
| Earnings Per Share (₹) | 1.02 | 1.07 | 1.16 | 0.70 | 3.26 | 4.71 | 5.11 | 3.50 | 6.45 | 11.03 | 7.81 | 3.93 | 2.71 | 5.07 | 5.91 | 4.05 |
Related Pages for IOL Chemicals & Pharmaceuticals
Additional stock information and data for IOLCP
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| Total Assets | 2,382 | 2,244 | 2,022 | 1,962 |
| Current Assets | 1,151 | 1,120 | 920 | 1,081 |
| Fixed Assets | 1,171 | 933 | 752 | 561 |
| Capital Work in Progress | 22 | 101 | 90 | 105 |
| Investments | 21 | 20 | 20 | 2 |
| Other Assets | 1,169 | 1,190 | 1,161 | 1,294 |
| LIABILITIES | ||||
| Total Liabilities | ||||
| Current Liabilities | 85 | 73 | 58 | 57 |
| Non-Current Liabilities | ||||
| SHAREHOLDERS' EQUITY | ||||
| Total Equity | 1,688 | 1,612 | 1,508 | 1,392 |
| Share Capital | 59 | 59 | 59 | 59 |
| Reserves & Surplus | 1,629 | 1,553 | 1,449 | 1,334 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 |
|---|---|---|---|---|
| Operating Activities | 179 | 290 | 122 | 93 |
| Investing Activities | -154 | -191 | -120 | -121 |
| Financing Activities | 46 | -93 | -4 | -2 |
| Net Cash Flow | 71 | 6 | -2 | -29 |